ABI
BTX.WS

Adamant Biomedical Investments’s BioTime Inc Warrants (Expiring October 1, 2018) BTX.WS Stock Holding History

Adamant Biomedical Investments’s Portfolio BTX.WS Stock Details BTX.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$2K Buy
+2,294
New +$2.49K ﹤0.01% 101

Other funds holding BTX.WS

Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCA
Private Capital Advisors Darien, Connecticut $1.14B AUM 48.66% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $29.3B AUM 38.15% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return

Adamant Biomedical Investments's BTX.WS Position: Q4 2014 in Review

Adamant Biomedical Investments opened a new position in BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) in Q4 2014: 2,294 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #101 among its holdings.

37 funds tracked by Wall St. Rank hold BTX.WS as of Q4 2014.

  • Adamant Biomedical Investments held 2,294 shares of BioTime Inc Warrants (Expiring October 1, 2018) worth $2K as of Q4 2014.
  • BioTime Inc Warrants (Expiring October 1, 2018) was a new Adamant Biomedical Investments position in Q4 2014.
  • BioTime Inc Warrants (Expiring October 1, 2018) made up ﹤0.01% of Adamant Biomedical Investments's portfolio in Q4 2014, its #101 holding.
  • 37 funds tracked by Wall St. Rank held BioTime Inc Warrants (Expiring October 1, 2018) as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.